# David J. Kwiatkowski

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-j-kwiatkowski/

## Facts

| Field | Value |
| --- | --- |
| Citations | 72,016 |
| Field | Tuberous Sclerosis Complex Research |
| h-index | 134 |
| i10-index | 387 |
| OpenAlex ID | https://openalex.org/A5100620133 |
| ORCID iD | https://orcid.org/0000-0002-5668-5219 |
| Works | 1,004 |

## Researcher papers

Showing 12 of 17.

- [Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing](https://scholariq.org/papers/mapping-the-hallmarks-of-lung-adenocarcinoma-with-massively-parallel-sequencing/)
- [Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs](https://scholariq.org/papers/using-multiplexed-assays-of-oncogenic-drivers-in-lung-cancers-to-select-targeted/)
- [Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference](https://scholariq.org/papers/tuberous-sclerosis-complex-diagnostic-criteria-update-recommendations-of-the/)
- [Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology](https://scholariq.org/papers/updated-molecular-testing-guideline-for-the-selection-of-lung-cancer-patients/)
- [The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma](https://scholariq.org/papers/the-somatic-genomic-landscape-of-chromophobe-renal-cell-carcinoma/)
- [Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference](https://scholariq.org/papers/tuberous-sclerosis-complex-surveillance-and-management-recommendations-of-the/)
- [The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma](https://scholariq.org/papers/the-cancer-genome-atlas-comprehensive-molecular-characterization-of-renal-cell/)
- [Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations](https://scholariq.org/papers/updated-international-tuberous-sclerosis-complex-diagnostic-criteria-and/)
- [Assessment of Resistance Mechanisms and Clinical Implications in Patients With<i>EGFR</i>T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib](https://scholariq.org/papers/assessment-of-resistance-mechanisms-and-clinical-implications-in-patients-with-i/)
- [A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations](https://scholariq.org/papers/a-pan-cancer-proteogenomic-atlas-of-pi3k-akt-mtor-pathway-alterations/)
- [Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth](https://scholariq.org/papers/mammalian-target-of-rapamycin-up-regulation-of-pyruvate-kinase-isoenzyme-type-m2/)
- [mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice](https://scholariq.org/papers/mtorc1-activation-in-podocytes-is-a-critical-step-in-the-development-of-diabetic/)

## Researcher topics

- [Tuberous Sclerosis Complex Research](https://scholariq.org/topics/tuberous-sclerosis-complex-research-2/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.